News
10h
Zacks Investment Research on MSNEMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related ItchGSK plc GSK announced that the European Medicines Agency has accepted its marketing authorization application (MAA) seeking approval of its investigational ileal bile acid transporter (“IBAT”) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results